42098-25-9Relevant articles and documents
Synthesis and Biological Profiling of Pyrazolo-Fused 7-Deazapurine Nucleosides
Fleuti, Marianne,Bártová, Kate?ina,Slavětínská, Lenka Po?tová,Tlou?t'Ová, Eva,Tichy, Michal,Gurská, Soňa,Pavli?, Petr,D?ubák, Petr,Hajdúch, Marián,Hocek, Michal
, p. 10539 - 10551 (2020/09/18)
A series of 8-substituted 1-methyl-1,4-dihydropyrazolo[3′,4′:4,5]pyrrolo[2,3-d]pyrimidine (methylpyrazolo-fused 7-deazapurine) ribonucleosides have been designed and synthesized. Two synthetic approaches to the key heterocyclic aglycon 7, (i) a six-step c
NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
-
Paragraph 0385-0387, (2020/08/25)
Compound of formula (I): wherein A1, A2, Ra, Rb, Rc, Rd, R3, R4, X, Y and G are as defined in the description, and their use in the manufacture of medicaments.
Kinase inhibitor, and preparation and application of kinase inhibitor
-
Paragraph 0237-0239; 0242; 0243; 0290; 0294, (2018/09/11)
The invention provides a compound shown as a formula (I), or a stereoisomer, a tautomer, nitrogen oxide, metabolite, a prodrug, pharmaceutically acceptable salt or solvate of the compound, and application of the compound to preparing drugs or drug compositions for treating Pim kinase-mediated diseases.